Table 2 –
iPCa | |
No | 1103 (94%) |
Yes | 74 (6.4%) |
T stage [N(%)] | |
T1a | 64 (86%) |
T1b | 10 (14%) |
Gleason score [N(%)] | |
6 | 67 (91%) |
7 | 5 (6.2%) |
>7 | 2 (2.5%) |
Keys: BPH= benign prostatic hyperplasia; iPCa= incidental prostate cancer
iPCa | |
No | 1103 (94%) |
Yes | 74 (6.4%) |
T stage [N(%)] | |
T1a | 64 (86%) |
T1b | 10 (14%) |
Gleason score [N(%)] | |
6 | 67 (91%) |
7 | 5 (6.2%) |
>7 | 2 (2.5%) |
Keys: BPH= benign prostatic hyperplasia; iPCa= incidental prostate cancer